Q1 2026 Earnings Call Transcript January 8, 2026 Simulations Plus, Inc. misses on earnings expectations. Reported EPS is ...
5don MSN
Simulations Plus maintains $79M–$82M revenue guidance for 2026 while accelerating AI integration
Q1 2026 Management View Shawn O'Connor, Chief Executive Officer, stated that "we delivered on the first quarter top line ...
(SLP) on Thursday reported earnings of $676,000 in its fiscal first quarter. The Research Triangle Park, North Carolina-based company said it had profit of 3 cents per share. Earnings, adjusted for ...
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced the ...
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...
Simulations Plus is benefiting from the growing use of computational tools in drug discovery, which would be boosted by the FDA Modernization Act 2.0. The biosimulation market is highly fragmented and ...
Simulation Plus' total return over-performed the Dow average for my 54 month test period by 390.62%, which is fantastic. Simulation Plus' three-year past CAGR of 25% is well above average and will ...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback